Vertraagde tijd
London S.E.
17:35:25 13-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
41
GBX
|
+5,13%
|
|
+9,33%
|
-1,20%
|
Fiscaal tijdperk: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
33.864
|
28.065
|
79.096
|
68.969
|
65.222
|
54.604
|
-
|
-
|
Bedrijfswaarde
1 |
33.864
|
37.934
|
86.052
|
80.148
|
65.222
|
60.560
|
55.482
|
50.144
|
K/w-verhouding
|
11,2
x
|
7,98
x
|
15,4
x
|
13,5
x
|
14,1
x
|
9,95
x
|
8,11
x
|
6,61
x
|
Dividendrendement
|
1,8%
|
2,17%
|
1,97%
|
2,26%
|
-
|
3,39%
|
4,29%
|
5,22%
|
Marktkapitalisatie/omzet
|
1,48
x
|
1,1
x
|
2,68
x
|
1,99
x
|
1,66
x
|
1,23
x
|
1,08
x
|
0,96
x
|
Bedrijfswaarde/omzet
|
1,48
x
|
1,48
x
|
2,92
x
|
2,31
x
|
1,66
x
|
1,36
x
|
1,1
x
|
0,88
x
|
Bedrijfswaarde/EBITDA
|
5,64
x
|
5,64
x
|
11,1
x
|
9,38
x
|
-
|
6,07
x
|
4,89
x
|
3,85
x
|
Bedrijfswaarde/FCF
|
-23,2
x
|
11,5
x
|
24,6
x
|
34,9
x
|
-
|
12,4
x
|
9,7
x
|
7,3
x
|
FCF Yield
|
-4,3%
|
8,7%
|
4,06%
|
2,87%
|
-
|
8,08%
|
10,3%
|
13,7%
|
Price to Book
|
1,14
x
|
0,86
x
|
2,14
x
|
1,7
x
|
-
|
1,1
x
|
1,01
x
|
0,91
x
|
Aantal aandelen (in duizenden)
|
446.112
|
446.112
|
446.112
|
446.112
|
446.112
|
446.112
|
-
|
-
|
Referentieprijs
2 |
75,91
|
62,91
|
177,3
|
154,6
|
146,2
|
122,4
|
122,4
|
122,4
|
Datum van publicatie
|
11-11-19
|
11-11-20
|
02-11-21
|
08-11-22
|
01-11-23
|
-
|
-
|
-
|
Fiscaal tijdperk: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
22.817
|
25.612
|
29.494
|
34.669
|
39.267
|
44.506
|
50.423
|
57.171
|
EBITDA
1 |
6.009
|
6.723
|
7.765
|
8.543
|
-
|
9.974
|
11.358
|
13.037
|
Bedrijfsresultaat (EBIT)
1 |
5.066
|
5.609
|
6.651
|
6.901
|
7.216
|
7.955
|
9.111
|
10.469
|
Operationele Marge
|
22,2%
|
21,9%
|
22,55%
|
19,91%
|
18,38%
|
17,87%
|
18,07%
|
18,31%
|
Resultaat voor belastingen (EBT)
1 |
3.946
|
4.653
|
6.378
|
6.687
|
6.069
|
7.122
|
8.499
|
10.153
|
Nettowinst (verlies)
1 |
3.033
|
3.515
|
5.141
|
5.123
|
4.612
|
5.251
|
6.244
|
7.464
|
Nettomarge
|
13,29%
|
13,72%
|
17,43%
|
14,78%
|
11,74%
|
11,8%
|
12,38%
|
13,06%
|
WPA
2 |
6,800
|
7,882
|
11,49
|
11,48
|
10,34
|
12,30
|
15,10
|
18,53
|
Free Cash Flow
1 |
-1.457
|
3.299
|
3.498
|
2.299
|
-
|
4.894
|
5.719
|
6.868
|
FCF-marge
|
-6,38%
|
12,88%
|
11,86%
|
6,63%
|
-
|
11%
|
11,34%
|
12,01%
|
Kasstroomconversie (ebitda)
|
-
|
49,07%
|
45,04%
|
26,91%
|
-
|
49,07%
|
50,35%
|
52,68%
|
Kasstroomconversie (nettowinst)
|
-
|
93,86%
|
68,04%
|
44,87%
|
-
|
93,21%
|
91,59%
|
92,02%
|
Dividend per aandeel
2 |
1,364
|
1,364
|
3,500
|
3,500
|
-
|
4,155
|
5,255
|
6,385
|
Datum van publicatie
|
11-11-19
|
11-11-20
|
02-11-21
|
08-11-22
|
01-11-23
|
-
|
-
|
-
|
Fiscaal tijdperk: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
9.869
|
6.956
|
11.179
|
-
|
5.956
|
878
|
-
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
4.460
|
Hefboom (schuld/ebitda)
|
-
|
1,468
x
|
0,8958
x
|
1,309
x
|
-
|
0,5972
x
|
0,0773
x
|
-
|
Free Cash Flow
1 |
-1.457
|
3.299
|
3.498
|
2.299
|
-
|
4.894
|
5.719
|
6.868
|
ROE (netto-inkomsten/eigen vermogen)
|
10,6%
|
11,2%
|
14,8%
|
13,2%
|
-
|
11,4%
|
12,7%
|
14,1%
|
ROA (netto-inkomsten/totale activa)
|
6,53%
|
7,08%
|
10%
|
-
|
-
|
7,7%
|
9,1%
|
10,7%
|
Totale activa
1 |
46.476
|
49.642
|
51.182
|
-
|
-
|
68.190
|
68.615
|
69.760
|
Nettoactief per aandeel
2 |
66,30
|
72,80
|
83,00
|
91,00
|
-
|
111,0
|
122,0
|
135,0
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
2.244
|
2.526
|
2.915
|
-
|
2.090
|
1.000
|
1.000
|
Capex/omzet
|
-
|
8,76%
|
8,56%
|
8,41%
|
-
|
4,7%
|
1,98%
|
1,75%
|
Datum van publicatie
|
11-11-19
|
11-11-20
|
02-11-21
|
08-11-22
|
01-11-23
|
-
|
-
|
-
|
Laatste slotkoers
122,4
BDT Gemiddelde koersdoel
168,3
BDT Spread / Gemiddelde doel +37,53% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +29,98% | 682 mld. | | +30,34% | 586 mld. | | -3,52% | 364 mld. | | +18,59% | 327 mld. | | +4,07% | 285 mld. | | +16,21% | 240 mld. | | +9,66% | 209 mld. | | -6,83% | 203 mld. | | +7,09% | 165 mld. |
Farmaceutische producten - Andere
|